Agreements

Date: 2017-08-10

Type of information: Opening of new premises

Compound: Reprocell Centre for Predictive Drug Discovery

Company: Reprocell (Japan) Reprocell Europe (UK)

Therapeutic area: Technology - Services

Type agreement: opening of new premises

Action mechanism:

Disease:

Details:

• On July 5, 2016, Reprocell, a Japanese regenerative medicine company, has announced that two of its Group companies, Biopta and Reinnervate, will merge to form a new company, Reprocell Europe. The merger is aimed at strengthening Reprocell’s pharmaceutical industry-targeted drug discovery services and products through the integration of Biopta’s human tissue services with Reinnervate’s stem cell and 3D cell culture expertise.
Reprocell Europe will operate from new headquarters in Glasgow with an established production and distribution site in Sedgefield. The company aims to grow the workforce significantly over the next three years and plans to move to larger premises in Glasgow within the next nine months.
Biopta and Reinnervate have been recently acquired by Reprocell. The companies have synergies and complementary offerings. Biopta is specialised in outsourced drug discovery services through the use of ethically-sourced human tissues while Reinnervate’s expertise is focused on 3D cell culture and stem cell technology.

Financial terms:

Latest news:

• On August 10, 2017, Reprocell Europe has opened its European headquarters in Glasgow. The Reprocell Centre for Predictive Drug Discovery at West of Scotland Science Park was inaugurated by Scotland’s First Minister, Nicola Sturgeon. The new headquarters will enable the company to strengthen its pharmaceutical industry-targeted drug discovery services and translational research, and generate new employment opportunities in Scotland.
This relocation to the West of Scotland Science Park was supported by £150,000 of Regional Selective Assistance from Scottish Enterprise in December 2016. Since then, Reprocell has invested a further £630,000 to expand its European headquarters and develop its product and service offering.